MNTL
Tema Neuroscience and Mental Health ETF · NAS
- Category Equity
- Expense Ratio 0.75%
- Listing Date Jan 23, 2024
- Volume 1,008.0
- Market Cap (AUM) $11.04M
Performance
+3.03%
1W
-1.24%
1M
-1.93%
3M
-0.81%
6M
-0.81%
YTD
-0.81%
1Y
Top Holdings
-
Name
Symbol%Assets
- Eli Lilly and CompanyLLY5.04%
- Vertex Pharmaceuticals IncorporatedVRTX4.70%
- Neurocrine Biosciences, Inc.NBIX4.68%
- Regeneron Pharmaceuticals, Inc.REGN4.40%
- Biogen Inc.BIIB4.21%
- Stryker CorporationSYK3.73%
- argenx SE ADRARGX3.67%
- DexCom, Inc.DXCM3.52%
- Day One Biopharmaceuticals, Inc.DAWN3.26%
- Crinetics Pharmaceuticals IncCRNX3.23%
Technical Analysis of MNTL 2024-05-03
Overview:
In analyzing the technical indicators for MNTL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
Page 1 of 1
previousnext